Abcam Mergers & Acquisitions

Abcam M&A Summary

Abcam has acquired 9 companies of its own, including 2 in the last 5 years. A total of 3 acquisitions came from private equity firms.

Abcam’s largest acquisition to date was in 2021, when it acquired BioVision for $340M. Abcam has acquired in 4 different US states, and 2 countries. The Company’s most targeted sectors include life science (100%).

M&A Summary

  • M&A Total Activity8
    • M&A Buy Activity8
  • Total Sectors Invested 1
  • Total Countries Invested 2
  • M&A Buy/Sell Connections 4

Abcam

Abcam Plc

Discovery Drive Cambridge Biomedical Campus,
Cambridge, CB2 0AX
United Kingdom,
+44 12 2369 6000
www.abcam.com

All (8) Buy (8) Sell (-)
Date Target Value
$mlns
Transaction Type Acquirer Seller SRC
Link
2021-08-02 BioVision · Life Science
Milpitas, California · www.biovision.com

BioVision is a privately-held life science company that develops and offers a wide variety of products including assay kits, antibodies, recombinant proteins & enzymes, and other innovative research tools for studying Apoptosis, Metabolism, Cell Proliferation, Cellular Stress, Cell Damage and Repair, Diabetes, Obesity and Metabolic Syndrome, Stem Cell Biology, Gene Regulation, Signal Transduction, etc. BioVision was formed in 1999 and is based in Milpitas, California.

Revenue (mlns) 34 USD
340
10.1x REVENUE
Add-on Acquisition

Abcam
Advisor: Latham & Watkins

-

Try Mergr Free — See This and 220,573+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 214K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 83K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.